| Name | Rite Aid Pharmacy #01217 |
|---|---|
| Organization Name | Rite Aid Of Ohio Inc |
| Location | 5765 Secor Rd, Toledo, Ohio 43623 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (419) 473-2451 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Research funded by the National Institutes of Health suggests that exposure to specific combinations of allergens and bacteria within the first year of life may protect children from wheezing and allergic disease.
Scientists at the Bellvitge Biomedical Research Institute in Barcelona, Spain have found new evidence for the role of epigenetic changes (those heritable alterations in gene expression caused by mechanisms other than changes in DNA sequence) on premature aging diseases.
Chemokine Therapeutics has announced that it has entered into an agreement with The University of Texas M. D. Anderson Cancer Center of Houston, Texas to study the Company's lead anti-cancer compound, CTCE-9908, a chemokine CXCR4 antagonist.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
Empa, the Swiss Federal Laboratories for Materials Science and Technology, is part of the European Nanomedicine Characterization Laboratory, a European project funded by the EU framework program «Horizon 2020.
› Verified 4 days ago
| NPI Number | 1427167758 |
| Organization Name | RITE AID OF OHIO INC |
| Doing Business As | RITE AID PHARMACY 01217 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5765 Secor Road, Toledo, OH 43623 |
| Phone Number | 419-473-2451 |
News Archive
Research funded by the National Institutes of Health suggests that exposure to specific combinations of allergens and bacteria within the first year of life may protect children from wheezing and allergic disease.
Scientists at the Bellvitge Biomedical Research Institute in Barcelona, Spain have found new evidence for the role of epigenetic changes (those heritable alterations in gene expression caused by mechanisms other than changes in DNA sequence) on premature aging diseases.
Chemokine Therapeutics has announced that it has entered into an agreement with The University of Texas M. D. Anderson Cancer Center of Houston, Texas to study the Company's lead anti-cancer compound, CTCE-9908, a chemokine CXCR4 antagonist.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
Empa, the Swiss Federal Laboratories for Materials Science and Technology, is part of the European Nanomedicine Characterization Laboratory, a European project funded by the EU framework program «Horizon 2020.
› Verified 4 days ago
News Archive
Research funded by the National Institutes of Health suggests that exposure to specific combinations of allergens and bacteria within the first year of life may protect children from wheezing and allergic disease.
Scientists at the Bellvitge Biomedical Research Institute in Barcelona, Spain have found new evidence for the role of epigenetic changes (those heritable alterations in gene expression caused by mechanisms other than changes in DNA sequence) on premature aging diseases.
Chemokine Therapeutics has announced that it has entered into an agreement with The University of Texas M. D. Anderson Cancer Center of Houston, Texas to study the Company's lead anti-cancer compound, CTCE-9908, a chemokine CXCR4 antagonist.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
Empa, the Swiss Federal Laboratories for Materials Science and Technology, is part of the European Nanomedicine Characterization Laboratory, a European project funded by the EU framework program «Horizon 2020.
› Verified 4 days ago
Health Care Solutions Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2950 Centennial Rd, Toledo, Ohio 43617 Phone: (419) 842-8040 | |
Rite Aid Pharmacy #07817 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7504 W Central Ave, Toledo, Ohio 43617 Phone: (419) 841-8525 | |
Rite Aid Pharmacy #06683 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3911 Secor Rd, Toledo, Ohio 43623 Phone: (419) 472-8027 | |
Rite Aid Pharmacy #01217 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5765 Secor Rd, Toledo, Ohio 43623 Phone: (419) 473-2451 | |
Rite Aid Pharmacy #02340 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2434 W Laskey Rd, Toledo, Ohio 43613 Phone: (419) 473-1221 |